Votrient
Brand for: Pazopanib
My Prescription
Payment
Select pharmacy
$3,471.31
$30.00 due at pharmacy
$3,471.31 - $30.00 = $3,441.31
$3,441.31 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
AlbertsonsPowered by$3,471.31
Print or send this coupon to your phone
AlbertsonsPowered byAbout Votrient
Drug Details
Pazopanib, marketed as Votrient, is an oral medication used to treat advanced forms of kidney cancer (renal cell carcinoma) and soft tissue sarcoma in adults. It belongs to a group of cancer therapies known as tyrosine kinase inhibitors. Pazopanib works by targeting specific proteins, such as those in the VEGFR family, that are crucial for supplying blood to tumors. By inhibiting these proteins, the medication helps to reduce the tumor's blood supply, thereby slowing its growth. While effective, pazopanib may cause side effects, including diarrhea, high blood pressure, and changes in hair color. This medication is not recommended for use in children, particularly those under the age of 2, due to the risk of serious side effects. Always consult with a healthcare provider before starting any new treatment.
Price history for Votrient (brand) & Pazopanib (generic)
120 Tablets, 200MG
Average retail price for Votrient
Average retail price for Pazopanib
Average SaveHealth price for Pazopanib
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
Over the last 12 months, the average discount price of Votrient is $9754.25 using the SaveHealth savings card. That's an average savings of 55.80% on Votrient with our discount card.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Votrient (Pazopanib) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 200MG | 120 Tablets | $3,471.31 | $28.93 |
Votrient FAQs
Votrient is used for the treatment of advanced renal cell carcinoma and advanced soft tissue sarcoma in patients who have received prior chemotherapy.
Yes, Votrient (pazopanib) is considered a targeted therapy. It works by inhibiting specific proteins involved in the growth of cancer cells, particularly targeting the vascular endothelial growth factor receptors (VEGFR) and other tyrosine kinases. This helps to slow or stop the growth of tumors.
Pazopanib is not commonly associated with weight gain. In fact, it may cause weight loss in some patients. If there are concerns about weight changes while taking pazopanib, it is advisable to consult with a healthcare provider for further evaluation and guidance.
Pazopanib is used to treat advanced renal cell carcinoma and certain types of soft tissue sarcoma.
Yes, Votrient (pazopanib) can cause fatigue as a common side effect. Patients taking Votrient may experience varying levels of tiredness, and it is important for them to discuss any significant fatigue with their healthcare provider to manage this side effect effectively.